Last update: Aug. 12, 2014

Intralesional Bleomycin

High Risk for breastfeeding


Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T½.
Read the Comment.

It is a cytostatic agent that has been locally used in intralesional injection for the treatment of warts, cheloid scars and acne.

Because it has been shown to appear in appreciable amount in the blood another option should be chosen.

Drug is cleared from the body after 6 elimination half-life time.

Resuming breastfeeding is likely safer after 24 hours of pump-and-dump period.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Intralesional Bleomycin belongs to this group or family:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. baja - low %
Molecular weight 1416 daltons
Tmax 0,75 hours
T1/2 4 hours

References

  1. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Full text (link to original source) Full text (in our servers)

Total visits

2,055

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM